210 related articles for article (PubMed ID: 26871895)
1. A Brief Review of the Link between Environment and Male Reproductive Health: Lessons from Studies of Testicular Germ Cell Cancer.
Skakkebaek NE
Horm Res Paediatr; 2016; 86(4):240-246. PubMed ID: 26871895
[TBL] [Abstract][Full Text] [Related]
2. Is testicular dysgenesis syndrome a genetic, endocrine, or environmental disease, or an unexplained reproductive disorder?
Xing JS; Bai ZM
Life Sci; 2018 Feb; 194():120-129. PubMed ID: 29183799
[TBL] [Abstract][Full Text] [Related]
3. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis.
Bonde JP; Flachs EM; Rimborg S; Glazer CH; Giwercman A; Ramlau-Hansen CH; Hougaard KS; Høyer BB; Hærvig KK; Petersen SB; Rylander L; Specht IO; Toft G; Bräuner EV
Hum Reprod Update; 2016 Dec; 23(1):104-125. PubMed ID: 27655588
[TBL] [Abstract][Full Text] [Related]
4. Reproductive dysgenesis in wildlife: a comparative view.
Edwards TM; Moore BC; Guillette LJ
Int J Androl; 2006 Feb; 29(1):109-21. PubMed ID: 16466531
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disruptors and the male reproductive system.
Stukenborg JB; Mitchell RT; Söder O
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101567. PubMed ID: 34426080
[TBL] [Abstract][Full Text] [Related]
6. Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men.
Rodprasert W; Toppari J; Virtanen HE
Front Endocrinol (Lausanne); 2021; 12():706532. PubMed ID: 34690925
[TBL] [Abstract][Full Text] [Related]
7. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems.
Wohlfahrt-Veje C; Main KM; Skakkebaek NE
Clin Endocrinol (Oxf); 2009 Oct; 71(4):459-65. PubMed ID: 19222487
[TBL] [Abstract][Full Text] [Related]
8. Regional differences and temporal trends in male reproductive health disorders: semen quality may be a sensitive marker of environmental exposures.
Nordkap L; Joensen UN; Blomberg Jensen M; Jørgensen N
Mol Cell Endocrinol; 2012 May; 355(2):221-30. PubMed ID: 22138051
[TBL] [Abstract][Full Text] [Related]
9. Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.
Virtanen HE; Rajpert-De Meyts E; Main KM; Skakkebaek NE; Toppari J
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):501-5. PubMed ID: 16005920
[TBL] [Abstract][Full Text] [Related]
10. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
[TBL] [Abstract][Full Text] [Related]
11. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.
Hauser R; Skakkebaek NE; Hass U; Toppari J; Juul A; Andersson AM; Kortenkamp A; Heindel JJ; Trasande L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1267-77. PubMed ID: 25742517
[TBL] [Abstract][Full Text] [Related]
12. [Effects of endocrine disrupting chemicals on male reproductive function--epidemiological views].
Nozawa S; Iwamoto T
Nihon Eiseigaku Zasshi; 2006 Jan; 61(1):32-7. PubMed ID: 16506652
[TBL] [Abstract][Full Text] [Related]
13. Effects of the prenatal environment on cryptorchidism: A narrative review.
Mitsui T
Int J Urol; 2021 Sep; 28(9):882-889. PubMed ID: 34075642
[TBL] [Abstract][Full Text] [Related]
14. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer.
Hoei-Hansen CE; Holm M; Rajpert-De Meyts E; Skakkebaek NE
J Pathol; 2003 Jul; 200(3):370-4. PubMed ID: 12845633
[TBL] [Abstract][Full Text] [Related]
15. Is Testicular Germ Cell Cancer Estrogen Dependent? The Role of Endocrine Disrupting Chemicals.
Fénichel P; Chevalier N
Endocrinology; 2019 Dec; 160(12):2981-2989. PubMed ID: 31617897
[TBL] [Abstract][Full Text] [Related]
16. Environmental factors and testicular function.
Giwercman A; Giwercman YL
Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):391-402. PubMed ID: 21397206
[TBL] [Abstract][Full Text] [Related]
17. Environment, testicular dysgenesis and carcinoma in situ testis.
Olesen IA; Sonne SB; Hoei-Hansen CE; Rajpert-De Meyts E; Skakkebaek NE
Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):462-78. PubMed ID: 17875492
[TBL] [Abstract][Full Text] [Related]
18. Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection.
Toppari J; Virtanen HE; Main KM; Skakkebaek NE
Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):910-9. PubMed ID: 20865786
[TBL] [Abstract][Full Text] [Related]
19. Changes in male reproductive health and effects of endocrine disruptors in Scandinavian countries.
Toppari J; Haavisto AM; Alanen M
Cad Saude Publica; 2002; 18(2):413-20. PubMed ID: 11923882
[TBL] [Abstract][Full Text] [Related]
20. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
